POWER OF KNOWLEDGE

Insight Center: News

Yvonne M. McKenzie Named to Food and Drug Law Institute's Food and Dietary Supplements Committee

11/08/2017
Yvonne M. McKenzie Named to Food and Drug Law Institute's Food and Dietary Supplements Committee

Pepper partner Yvonne M. McKenzie has been appointed to the Food and Drug Law Institute’s (FDLI’s) Food and Dietary Supplements Committee, commencing January 1, 2018. 

FDLI is a national membership organization that engages the food and drug law community. FDLI offers education, training, publications and professional engagement opportunities for stakeholders to inform innovative public policy, law and regulation within the food and beverage industry. As a member of the Food and Dietary Supplements Committee, Ms. McKenzie will work in conjunction with FDLI to ensure that the programming they provide to the food and dietary supplements industry, including the Food Advertising, Labeling, and Litigation Conference, is timely and relevant and remains at a level geared towards advanced professionals.

Ms. McKenzie is a member of the firm’s Health Sciences Department and Food and Beverage Industry Group. She focuses her practice on counseling and defending companies with products regulated by the FDA, including prescription medications, food, beverages and cosmetics. She has extensive experience litigating class action suits brought by consumers and third-party payors alleging false advertising and fraud in violation of state consumer fraud and unfair trade practice laws. Ms. McKenzie has also defended clients against actions filed by state attorneys general and government entities seeking restitution and civil penalties.

Ms. McKenzie routinely advises clients in the food, drug and cosmetic industries on regulatory compliance and risk assessments and mitigation strategies, including counseling on product recalls, advertising and other promotional activities, as well as statements made in labeling, scientific disclosures, press releases and regulatory submissions to U.S. and foreign regulatory agencies.